Jagruti Y. Patil

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment.

Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment.

Journal: Cytometry. Part B, Clinical cytometry

Published: February 01, 2026

TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia.

TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia.

Journal: Molecular carcinogenesis

Published: January 15, 2026

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Journal: Cytometry. Part B, Clinical cytometry

Published: December 10, 2025

Utility of leukocyte-associated immunoglobulin-like receptor-1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B-cell non-Hodgkin lymphoma.

Utility of leukocyte-associated immunoglobulin-like receptor-1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B-cell non-Hodgkin lymphoma.

Journal: Cytometry. Part B, Clinical cytometry

Published: December 29, 2023

Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant.

Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant.

Journal: HemaSphere

Published: November 10, 2023

15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.

15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.

Journal: European journal of haematology

Published: June 21, 2023

Acute basophilic leukemia in a patient with down syndrome: A case report and review of literature.

Acute basophilic leukemia in a patient with down syndrome: A case report and review of literature.

Journal: International journal of laboratory hematology

Published: March 21, 2023

Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent.

Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent.

Journal: Cytometry. Part B, Clinical cytometry

Published: June 19, 2022

CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.

CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.

Journal: Cytometry. Part B, Clinical cytometry

Published: October 06, 2019

Cerium doped MgFe2O4 nanocomposites: highly sensitive and fast response-recoverable acetone gas sensor.

Cerium doped MgFe2O4 nanocomposites: highly sensitive and fast response-recoverable acetone gas sensor.

Journal: Heliyon

Published: November 27, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026